Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXW80V
|
||||
Drug Name |
(S)-1-(1H-Indol-4-yloxy)-3-[4-(6-methyl-benzo[b]thiophen-2-yl)-piperidin-1-yl]-propan-2-ol
|
||||
Synonyms |
CHEMBL60748
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C25H28N2O2S
|
||||
Canonical SMILES |
Cc1ccc2cc(sc2c1)C3CCN(C[C@H](O)COc4cccc5[nH]ccc45)CC3
|
||||
InChI |
InChI=1S/C25H28N2O2S/c1-17-5-6-19-14-25(30-24(19)13-17)18-8-11-27(12-9-18)15-20(28)16-29-23-4-2-3-22-21(23)7-10-26-22/h2-7,10,13-14,18,20,26,28H,8-9,11-12,15-16H2,1H3/t20-/m0/s1
|
||||
InChIKey |
IKEGNVUTXPMWNG-FQEVSTJZSA-N
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
5HT2 type receptor mediated signaling pathway | |||||
5HT3 type receptor mediated signaling pathway | |||||
5HT4 type receptor mediated signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.